Multiple endocrine neoplasia type 2 laboratory findings
Multiple endocrine neoplasia type 2 Microchapters |
Differentiating Multiple endocrine neoplasia type 2 from other Diseases |
---|
Diagnosis |
Treatment |
Multiple endocrine neoplasia type 2 laboratory findings On the Web |
American Roentgen Ray Society Images of Multiple endocrine neoplasia type 2 laboratory findings |
FDA on Multiple endocrine neoplasia type 2 laboratory findings |
CDC on Multiple endocrine neoplasia type 2 laboratory findings |
Multiple endocrine neoplasia type 2 laboratory findings in the news |
Blogs on Multiple endocrine neoplasia type 2 laboratory findings |
Directions to Hospitals Treating Multiple endocrine neoplasia type 2 |
Risk calculators and risk factors for Multiple endocrine neoplasia type 2 laboratory findings |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Ammu Susheela, M.D. [2]
Overview
Laboratory findings consistent with the diagnosis of multiple endocrine neoplasia type 2 include hypercalcemia, hypophosphatemia, elevated parathyroid hormone, and elevated norepinephrine.
Laboratory Findings
- Laboratory findings consistent with the diagnosis of multiple endocrine neoplasia type 2 are tabulated below.
Test | Findings |
---|---|
Metabolic | Hypophosphatemia Hypercalcemia Elevated calcitonin Elevated epinephrine Elevated norepinephrine Elevated metanephrine Elevated vanillylmandelic acid Elevated parathyroid hormone Elevated pentagastrin |
Urinalysis | Elevated norepinephrine Elevated metanephrine Elevated vanillylmandelic acid |
Adapted from Marquard J, Eng C. Multiple Endocrine Neoplasia Type 2. 1999 Sep 27 [Updated 2015 Jun 25]. In: Pagon RA, Adam MP, Ardinger HH, et al., editors. GeneReviews® [Internet]. Seattle (WA): University of Washington, Seattle; 1993-2015. Available from: http://www.ncbi.nlm.nih.gov/books/NBK1257/[1] |
References
|